Effect of Systemic Isotretinoin on serum Irisin level in Acne Vulgaris patients | ||||
| SVU-International Journal of Medical Sciences | ||||
| Volume 8, Issue 2, July 2025, Page 332-348 PDF (546.91 K) | ||||
| Document Type: Original research articles | ||||
| DOI: 10.21608/svuijm.2025.392359.2192 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Soheir Abdel-Hamid   1; Nahed Mohamed Abou Elwfa1; Essra Abass Abd Allah2; Hassan M. Ibrahim1
| ||||
| 1Dermatology, Venereology, and Andrology Department, Faculty of Medicine, South Valley University, Qena, Egypt. | ||||
| 2Clinical Pathology Department, Faculty of Medicine, South Valley University, Qena, Egypt | ||||
| Abstract | ||||
| Background: Acne vulgaris (AV) is a chronic inflammatory dermatological disorder affecting pilosebaceous unit. Clinically, it manifested as comedones, pustules, papules, nodules, cysts, and scarring on the face and trunk. Objectives: Assess serum irisin levels in acne vulgaris, compare them with healthy controls, as well as analyze impact of oral isotretinoin on serum irisin in cases with AV. Patients and methods: A prospective randomized clinical interventional trial was enrolled patients diagnosed clinically with moderate and severe acne vulgaris 40 AV patients were split into two groups based on Global Evaluation Acne Scale : group 1 was moderate AV, group 2 was severe AV. Serum irisin was measured in AV patients before and after oral isotretinoin treatment and compared to the control group (group 3). Results: There was significant difference among three groups in median level of serum irisin before treatment (p = 0.002) i.e., median level was significantly lower in control group (32 [23 - 188] ng/ml) compared with both groups (moderate AV (38 (16-163) ng/ml) (p = 0.004) , severe AV (46 (25.5-113) ng/ml) (p = 0.008). After treatment, there was significant difference among three groups in median level of serum irisin (p = 0.017). There was a non-statistically significant difference among 2 groups regarding clinical improvement (p = 0.308), cases satisfaction (p = 0.527) and treatment side effects (p = 0.507). Conclusion: Serum irisin serves as a biomarker for disease etiology and a potential prognostic indicator for severity of AV. | ||||
| Keywords | ||||
| Acne vulgaris; Serum irisin; Systemic isotretinoin | ||||
|
Statistics Article View: 44 PDF Download: 14 |
||||
